84SA Stock Overview
SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company in worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
SLANG Worldwide Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.02 |
52 Week High | CA$0.041 |
52 Week Low | CA$0.013 |
Beta | 1.04 |
1 Month Change | -23.08% |
3 Month Change | -13.04% |
1 Year Change | -11.11% |
3 Year Change | -98.33% |
5 Year Change | -99.78% |
Change since IPO | -99.76% |
Recent News & Updates
Recent updates
Shareholder Returns
84SA | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 0% | 1.3% | 1.1% |
1Y | -11.1% | -28.6% | 1.9% |
Return vs Industry: 84SA exceeded the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: 84SA underperformed the German Market which returned 2% over the past year.
Price Volatility
84SA volatility | |
---|---|
84SA Average Weekly Movement | 33.6% |
Pharmaceuticals Industry Average Movement | 6.6% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 84SA's share price has been volatile over the past 3 months.
Volatility Over Time: 84SA's weekly volatility has increased from 28% to 34% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | n/a | John Moynan | slangww.com |
SLANG Worldwide Inc. operates as a cannabis consumer packaged goods company in worldwide. It offers cannabis vaporizers in various oil formulations; gummies; vapors for dry herbs and concentrates; and select genetics in vape cartridges, as well as cannabis to the medical and adult-use cannabis markets. The company serves its customers under O.pen, Alchemy Naturals, Firefly, Ceres, and Green House Seed Co X Strain Hunters brand names.
SLANG Worldwide Inc. Fundamentals Summary
84SA fundamental statistics | |
---|---|
Market cap | €5.44m |
Earnings (TTM) | -€13.22m |
Revenue (TTM) | €24.13m |
0.2x
P/S Ratio-0.4x
P/E RatioIs 84SA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
84SA income statement (TTM) | |
---|---|
Revenue | CA$35.34m |
Cost of Revenue | CA$17.06m |
Gross Profit | CA$18.28m |
Other Expenses | CA$37.65m |
Earnings | -CA$19.37m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.085 |
Gross Margin | 51.72% |
Net Profit Margin | -54.80% |
Debt/Equity Ratio | -562.8% |
How did 84SA perform over the long term?
See historical performance and comparison